| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 03/07/2007 | CN1925852A Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 03/06/2007 | US7186851 Facile method for synthesizing baccatin III compounds |
| 03/06/2007 | US7186849 C7 ester substituted taxanes |
| 03/06/2007 | US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/06/2007 | US7186722 active against sensitive and resistant species and against all development stages |
| 03/06/2007 | US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents |
| 03/01/2007 | WO2007022845A1 Novel materials for organic electroluminescent devices |
| 03/01/2007 | WO2006066147A3 Ambruticin vs compounds |
| 03/01/2007 | US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 02/28/2007 | EP1756080A1 Chromone derivatives useful as vanilloid antagonists |
| 02/28/2007 | EP1755613A2 Substituted cyclic urea derivatives |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1458703B1 Isochroman compounds for treatment of cns disorders |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/27/2007 | US7183421 Such as aldehyde, ketone, lactone, carboxylic acid ester, and carboxylic acid; by causing silica gel to carry the alcohol compound and N-oxyl compounds or corresponding N-hydroxy compounds as oxidation catalysts, and subjecting the alcohol compound to an electrolytic oxidation; organic solvent-free |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/22/2007 | WO2007022258A1 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/22/2007 | US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070042936 glycerol cyclic pyruvate derivates; inhibit the binding of an immobilized D-proline derivative to serum amyloid P componen; amyloidosis; Alzheimers disease; maturity onset diabetes mellitus |
| 02/22/2007 | CA2619790A1 Novel high affinity thiophene-based and furan-based kinase ligands |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/21/2007 | EP1754704A1 Diamidine compounds as DNA minor groove binders |
| 02/21/2007 | EP1753858A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 02/21/2007 | EP1753745A2 Pyrazinylmethyl lactam derivatives |
| 02/21/2007 | EP1753719A1 Substituted pyrrolidine-2-ones |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1918141A Aminodibenzodioxin derivative and organic electroluminescent device using same |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/15/2007 | WO2007018954A2 Application of a bioactive agent in a solvent composition to produce a target particle morphology |
| 02/15/2007 | WO2007018953A1 Preparation of nanoparticles |
| 02/15/2007 | WO2007018887A2 Application of a bioactive agent to a substrate |
| 02/15/2007 | WO2007018193A1 Novel cercosporamide derivative |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | CA2618622A1 Novel cercosporamide derivative |
| 02/14/2007 | EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
| 02/14/2007 | CN1914198A Method of stabilizing macrolide compound |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/13/2007 | US7176326 β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes |
| 02/13/2007 | US7176325 Esterification of a taxane molecules at the C-2' hydroxyl group, using an acid halide and a hindered base; forming paclitaxel, cephalomannine derivatives |
| 02/13/2007 | US7176236 Water-soluble etoposide analogs and methods of use thereof |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/08/2007 | US20070032486 5Ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
| 02/08/2007 | DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease |
| 02/07/2007 | EP1421079B1 Thiophenyl compounds as medicaments |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | CN1907986A Method for extracting nimbin |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/06/2007 | US7173141 Phenyl substitited lactone; prepared in optically pure form from meso-fiydrobenzoin; chemical intermediate for alpha -hydroxy acids and 1,2-diols using catalytic hydrogenation |
| 02/06/2007 | CA2238884C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 02/06/2007 | CA2214320C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/01/2007 | WO2007013830A1 Nitrocatechol derivatives as comt inhibitors |
| 02/01/2007 | CA2616377A1 Nitrocatechol derivatives as comt inhibitors |
| 01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297268C Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 01/30/2007 | US7169942 Cannabinoid derivatives, methods of making, and use thereof |
| 01/30/2007 | US7169930 Analogs of epothilone |
| 01/30/2007 | US7169446 photocurable ink composition for ink jet recording containing a cation polymerizable oxetane compound with high reactivity which can provide a high quality image, and an image formation method employing the photocurable ink composition |
| 01/30/2007 | CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 01/25/2007 | WO2007011629A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | WO2007009201A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | WO2006005682A3 Preparation of alpha-hydroxy and alpha-amino ketones |
| 01/25/2007 | WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 01/25/2007 | US20070021475 2-(2-chloro-6-fluoro-phenyl)-N-{cis-4-[4-(pyrrolidine-1-carbonyl)-[1,2,3]triazol-1-yl]-cyclohexyl}-acetamide; anxiety, depression, bipolar disorders, Parkinson's disease, schizophrenia and pain. |
| 01/25/2007 | CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | CA2615112A1 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | CN1902195A Modulators of cellular adhesion |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/23/2007 | US7166727 Product of a porous silica that may contain Zr, Al and/or Ti and an organic compound of K, Cs and/or Rb, with a pore volume of at least 0.3 cubic centimeters per gram of catalyst attributable to pores having a diameter of 65-3200 Angstroms; reacting a butyrolactone (especially G-valerolactone) with CH2O |
| 01/23/2007 | CA2331288C Aqueous process for manufacturing paroxetine solid dispersions |
| 01/23/2007 | CA2192186C Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/16/2007 | US7164033 Gas phase synthesis of methylene lactones using novel catalyst |
| 01/16/2007 | US7164032 Supercritical fluid phase synthesis of methylene lactones using novel catalyst field of invention |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |